Quarterly report [Sections 13 or 15(d)]

Stock-based Payments

v3.26.3
Stock-based Payments
9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Stock-based Payments

Note 7 – Stock-based Payments

 

Equity incentive Plans

 

2017 Stock Incentive Plan

 

On August 7, 2017, the Company’s stockholders approved, and the Company adopted the 2017 Stock Incentive Plan (“2017 Plan”). The 2017 Plan provides for the issuance of up to 2 shares of the Company’s Common Stock. Due to the rounding up of each restricted stock grant to the respective option holder after several reverse stock splits, the total rounded shares as of September 30, 2026, totaled 15 shares of restricted stock. These restricted shares have been issued pursuant to the 2017 Plan, and 0 shares of Common Stock remain available for issuance.

 

2018 Stock Incentive Plan

 

On December 7, 2018, the Company’s stockholders approved, and the Company adopted the 2018 Stock Incentive Plan (“2018 Plan”). On August 27, 2020, the 2018 Plan was modified to increase the total authorized shares available for future issuance. The 2018 Plan, as amended, provides for the issuance of up to 188 shares of the Company’s Common Stock. As of September 30, 2026, grants of RSUs and restricted stock to purchase 89 shares of Common Stock have been issued pursuant to the 2018 Plan, and 99 shares of Common Stock remain available for issuance.

 

 

2021 Stock Incentive Plan

 

On April 15, 2021, the Company’s stockholders approved, and the Company adopted the 2021 Stock Incentive Plan, (as amended the “2021 Plan”). The 2021 Plan provides for the issuance of up to 1,400,000 shares of the Company’s Common Stock. As of September 30, 2026, grants of RSUs and stock options to purchase 1,038,698 shares of Common Stock are outstanding pursuant to the 2021 Plan, and 361,302 shares of Common Stock remain available for issuance.

 

Stock Options

 

The following table summarizes the activities for the Company’s stock options for the nine months ended September 30, 2026: 

 

                      Weighted        
                      Average        
          Weighted     Weighted     Remaining        
    Number     Average     Average     Contractual     Aggregate  
    of     Exercise     Grant Date     Term     Intrinsic  
    Shares     Price     Fair Value     (years)     Value  
Balance at December 31, 2025     100,360     $ 24.66     $ 23.42       9.15     $ -  
Granted     687,500       4.98       3.82       8.93       -  
Exercised     -       -       -       -       -  
Forfeited     (126,509 )     15.27       13.86       8.58       -  
Canceled/Expired     (50 )     4,980.00       4,710.00       6.69       -  
Balance September 30, 2026     661,301       5.62       4.52       9.03     $ -  
Exercisable as of September 30, 2026     535,051       5.75       4.59       9.13     $ -  

 

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $0.85 for the Company’s Common Stock on September 30, 2026 and the closing stock price of $3.99 for the Company’s Common Stock on December 31, 2025.

 

During the three months ended September 30, 2026 and 2025, the Company recognized stock option expenses totaling $33,751 and $0, respectively. During the nine months ended September 30, 2026 and 2025, the Company recognized stock option expenses totaling $1,939,194 and $189,490, respectively.

 

The unamortized stock option expenses as of September 30, 2026 totaled $0.

 

Restricted Stock Units

 

On October 14, 2021, the Compensation Committee of the Board of Directors approved grants totaling 484 Restricted Stock Units to the Company’s then current six directors and then current seven key employees. Each RSU had a grant date fair value of $24,270 which will be amortized upon vesting into administrative expenses within the Consolidated Statements of Operations. Such RSUs were granted under the 2021 Plan. Vesting of each RSU is:

 

  ● One-third (33%) of each RSU will vest when the Company’s market capitalization is equal to or greater than $500,000,000 for at least ten trading days during any twenty (20) consecutive trading day period ending on or after December 15, 2021 and the fair market value of the Common Stock equals or exceeds $150.00 during such trading day period.
     
  ● One-third (33%) of each RSU will vest when the Company’s market capitalization is equal to or greater than $750,000,000 for at least ten trading days during any twenty (20) consecutive trading day period ending on or after December 15, 2021 and the fair market value of the Common Stock equals or exceeds $150.00 during such trading day period.
     
  ● The remaining awarded units will vest when the Company’s market capitalization is equal to or greater than $1,000,000,000 for at least ten trading days during any twenty (20) consecutive trading day period ending on or after December 15, 2021 and the fair market value of the Common Stock equals or exceeds $150.00 during such trading day period.
     
  ●

In the event that (i) a change in control occurs or (ii) the participant incurs a termination of service by the Company without cause or due to the participant’s death or total and permanent disability, then all unvested units shall become vested units immediately upon the occurrence of such event.

 

 

As of September 30, 2026 and 2025, none of the vesting milestones have been met, respectively.

 

On October 2, 2025, the Compensation Committee of the Board of Directors approved grants totaling 225,000 Restricted Stock Units to the Company’s then current five directors and Executive Chairman. Each RSU had a grant date fair value of $5.55 and vested immediately on the grant date. The resulting equity-based compensation was fully expensed in 2025 and recorded as part of administrative expenses within the Consolidated Statements of Operations. These RSUs were granted under the 2021 Plan.

 

The Compensation Committee of the Board of Directors approved several RSU grants to various consultants, an employee and a new board member in 2026. All issued RSUs have either vested or were forfeited. These RSUs were granted under the 2021 Plan

 

The following is the status of outstanding unvested RSUs outstanding as of September 30, 2026 and the changes for the nine months ended September 30, 2026:

 

          Weighted  
          Average  
    Number of     Grant Date  
    RSUs     Fair Value  
Balance at December 31, 2025     212,500     $ 6.67  
Share Adjustment     27,634       3.26  
Granted     311,114       3.94  
Vested     (354,373 )     5.11  
Forfeited     (196,875 )     4.68  
Canceled/Expired     -       -  
Balance at September 30, 2026     -     $  -  

 

As of September 30, 2026, the unamortized value of the RSUs was $0.